"Myocarditis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Descriptor ID |
D009205
|
| MeSH Number(s) |
C14.280.238.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myocarditis".
Below are MeSH descriptors whose meaning is more specific than "Myocarditis".
This graph shows the total number of publications written about "Myocarditis" by people in this website by year, and whether "Myocarditis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 0 | 3 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 4 | 0 | 4 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myocarditis" by people in Profiles.
-
Susceptibility to innate immune activation in genetically mediated myocarditis. J Clin Invest. 2024 May 16; 134(13).
-
Outcomes of rheumatic fever in Uganda: a prospective cohort study. Lancet Glob Health. 2024 Mar; 12(3):e500-e508.
-
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373.
-
Pulmonary embolism initially misdiagnosed as perimyocarditis in a young patient. Ann Card Anaesth. 2022 Jan-Mar; 25(1):100-102.
-
mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study. J Pediatr. 2022 04; 243:208-213.e3.
-
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents. AJR Am J Roentgenol. 2022 04; 218(4):651-657.
-
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases. Oncologist. 2021 12; 26(12):1052-1061.
-
Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr. 2021 11; 238:26-32.e1.
-
Six Month Follow-up of Patients With Multi-System Inflammatory Syndrome in Children. Pediatrics. 2021 10; 148(4).
-
Fulminant myocarditis and atrial fibrillation in child with acute COVID-19. J Electrocardiol. 2022 Jul-Aug; 73:150-152.